Towards Strengthening HIV Case Detection and Management: A Review of The Role of Oral Healthcare and Enhanced Laboratory Diagnostics

Abstract

An estimated 84.2 million people have suffered the disease since its discovery. Although the number of new cases decreased by 32% since 2010, it is most prevalent in Africa 68% [25.7 million], resulting in approximately 470,000 AIDS-related deaths with Nigeria having the highest number of people living with HIV/AIDS (PLWHA) in the region and the second highest globally. Rapid diagnostic tests (RDTs) have emerged as indispensable tools for point-of-care testing, providing quick results with minimal infrastructure requirements.

Dentists play a critical role in the early detection of HIV, as they are in a unique position to identify oral manifestations associated with the infection. The oral cavity is frequently the first site where symptoms of HIV appear, often even before individuals are aware of their serostatus. Dentists have a responsibility to be aware of the oral manifestations of HIV and to consider HIV infection in the differential diagnosis of these conditions. Additionally, dentists can play a proactive role in HIV screening by offering rapid HIV testing services in their dental.

With recent findings demonstrating the high transmissibility of HIV early in infection, and the potential benefit of early initiation of treatment, it is essential to identify as many infected individuals as possible. HIV testing is the key part of diagnosis and prevention efforts hence the need for synergy between oral health practitioners and laboratory diagnostic experts in bridging the gap of diagnosis and prevention among healthcare professionals.

Keywords:

Dentist, Detection, Diagnostics, Eradication, HIV, Laboratory

References

World Health Organization. WHO Africa Health Topics - HIV/AIDS. 2018 [cited 2023 Mar 6]. Available from: https://www.afro.who.int/health-topics/hivaids

UNAIDS. AIDSInfo: Number of people living with HIV. 2018 [cited 2023 Mar 6]. Available from: https://aidsinfo.unaids.org/

National Agency for the Control of AIDS (NACA). Revised National HIV and AIDS Strategic Framework 2019–2021: Future directions for the HIV/AIDS response in Nigeria. 2018 [cited 2023 Mar 6]. Available from: https://naca.gov.ng/wp-content/uploads/2019/03/NATIONAL-HIV-AND-AIDS-STRATEGIC-FRAMEWORK

Broder S. The development of antiretroviral therapy and its impact on the HIV-1/AIDS pandemic. Antiviral Res. 2010 Jan;85(1):1–18.

Tobias C. Oral health care: the forgotten need for HIV-positive populations in the continuum of care. Presented at: American Public Health Association Annual Meeting; 2007 Nov 7; Washington, DC.

McCarthy GM. Host factors associated with HIV-related oral candidiasis: a review. Oral Surg Oral Med Oral Pathol. 1992 Feb;73(2):181–6.

Patton LL, McKaig R, Strauss R, Rogers D, Eron JJ Jr. Changing prevalence of oral manifestations of HIV in the era of protease inhibitor therapy. Oral Surg Oral Med Oral Pathol Oral Radiol Endod. 2000 Mar;89(3):299–304.

Awofala AA, Ogundele OE. HIV epidemiology in Nigeria. Saudi J Biol Sci. 2018;25(4):697–703.

O’Brien-Carelli C, Steuben K, Stafford KA, Aliogo R, Alagi M, Johanns CK. Mapping HIV prevalence in Nigeria using small area estimates to develop a targeted HIV intervention strategy. PLoS One. 2022 Jun 8;17(6):e0268892.

World Population Review. HIV Rates by Country 2023 [Internet]. [cited 2023 Mar 6]. Available from: https://worldpopulationreview.com/country-rankings/hiv-rates-by-country

HIV Country Profiles [Internet]. [cited 2023 Mar 6]. Available from: https://cfs.hivci.org/index.html

Jahun I, Dirlikov E, Odafe S, Yakubu A, Boyd AT, Bachanas P, et al. Ensuring optimal community HIV testing services in Nigeria using an Enhanced Community Case-Finding Package (ECCP), Oct 2019–Mar 2020: Acceleration to HIV epidemic control. HIV AIDS Res Palliat Care. 2021;13:839–50.

Strengthening Integrated Delivery of HIV/AIDS Services, FHI 360. Implementing the surge HIV response in Akwa Ibom: an accelerated HIV epidemic control drive (technical brief).

Jwanle P, Ibiloye O, Obaje M, Ngwoke K, Usha T, Amoo O, et al. Accelerating HIV epidemic control in Benue State, Nigeria, 2019–2021: the APIN program experience. Ther Adv Infect Dis. 2023 Feb;10:20499361231153549.

Motayo BO, Usen U, Folarin BO, Okerentugba PO, Innocent-Adiele HC, Okonko IO. Detection and seroprevalence of HIV-1 & 2 antibodies in Abeokuta, Southwest Nigeria. Int J Virol Mol Biol. 2012;1(2):18–22.

Franco-Paredes C, Tellez I, del Rio C. Rapid HIV testing: a review of the literature and implications for the clinician. Curr HIV/AIDS Rep. 2006 Dec;3(4):169–75.

Saba AM, Abdullahi M, John B, Angulu S, Dogari J. Evaluation of the sensitivity and specificity of three rapid test kits used in the detection of HIV in public hospitals, Niger State, Nigeria. J Sci Res Med Biol Sci. 2022 Mar 12;3(1):1–6.

Cappello JM, Gunasekera A, Gunasekera D, Esfandiari J, Ippolito T. A multicentre performance evaluation of the DPP® HIV-1/2 assay. J Clin Virol. 2013 Dec;58:e59–64.

Odaibo GN, Donbraye E, Adewumi MO, Bakaery AS, Ibeh MA, Olaleye DO. Reliability of testing and potential impact on HIV prevention in Nigeria.

Olusola BA, Olaleye DO, Odaibo GN. Detection of early HIV-1 infection among febrile persons and blood donors in Oyo State, Nigeria. medRxiv. 2020 Apr 14.

National Institute of Dental and Craniofacial Research (NIDCR). Oral manifestations of HIV/AIDS [Internet]. 2023 [cited 2023 Dec 2]. Available from: https://www.nidcr.nih.gov/health-info/hiv-aids

Centers for Disease Control and Prevention (CDC). HIV/AIDS [Internet]. 2023 [cited 2023 Dec 2]. Available from: https://www.cdc.gov/hiv/default.html

World Health Organization. HIV/AIDS [Internet]. 2023 [cited 2023 Dec 2]. Available from: https://www.who.int/news-room/fact-sheets/detail/hiv-aids

Reznik DA. Oral manifestations of HIV disease. Top HIV Med. 2005;13(5):143–8.

Bajpai S, Pazare AR. Oral manifestations of HIV. Contemp Clin Dent. 2010;1(1):1–5.

Weinert M, Grimes RM, Lynch DP. Oral manifestations of HIV infection. Ann Intern Med. 1996 Sep 15;125(6):485–96.

Santella AJ, Schlub TE, Schifter M, Tolani M, Hillman RJ. Australian dentists’ perspectives on rapid HIV testing. Aust Dent J. 2016 Sep;61(3):270–6.

Parish CL, Siegel K, Liguori T, Abel SN, Pollack HA, Pereyra MR, et al. HIV testing in the dental setting: perspectives and practices of experienced dental professionals. AIDS Care. 2018;30(3):347–52.

Reznik DA. Screening for infectious diseases in the dental setting. Dent Clin North Am. 2012 Oct;56(4):809–18.

Centers for Disease Control and Prevention (CDC). Laboratory testing for the diagnosis of HIV infection: updated recommendations. CDC Stacks. 2014.

Yuksel P, Saribas S, Kuskucu M, et al. Problems encountered in conventional HIV 1/2 algorithms. Afr Health Sci. 2018;18(2):407–16.

Kania D, Truong TN, Montoya A, et al. Performance of fourth-generation HIV assays on filter paper. J Clin Virol. 2015;62:92–7.

Welles HC, King HAD, Nettey L, et al. Broad coverage of neutralization-resistant SIV strains by second-generation antibodies. PLoS Pathog. 2022;18(6):e1010574.

Din M, Waris A, Khan M, et al. The contemporary immunoassays for HIV diagnosis: a concise overview. Asian Biomed. 2023;17(1):3–12.

Vallefuoco L, Mazzarella C, Portella G. Fourth generation assays for HIV testing. Expert Rev Mol Diagn. 2016;16(7):723–32.

Rapid detection by the OraQuick ADVANCE® Rapid HIV 1/2 Antibody Test. PeerJ. 2018;6:e4430.

Kalou MB, Castro A, Watson A, et al. Evaluation of Chembio Dual Path Platform HIV-Syphilis Assay. Afr J Lab Med. 2016;5(1):433.

Figueroa C, Johnson C, Ford N, et al. Reliability of HIV RDTs for self-testing: systematic review and meta-analysis. Lancet HIV. 2018;5(6):e277–90.

Sirivichayakul S, Pankam T, Pattanachaiwit S, et al. Ability of Alere HIV Combo to diagnose acute HIV infection. Asian Pac J Allergy Immunol. 2021. doi:10.12932/AP-290521-1144

Pandori MW, Westheimer E, Gay C, et al. Multispot rapid HIV-1/HIV-2 differentiation assay: comparison with Western blot. J Clin Virol. 2013;58 Suppl 1:e92–6.

Shigemi U, Yamamura Y, Matsuda M, et al. Evaluation of Geenius HIV 1/2 confirmatory assay. J Clin Virol. 2022;152:105189.

Manak MM, Eller LA, Malia J, et al. Identification of acute HIV-1 infection by Aptima HIV-1 RNA qualitative assay. J Clin Microbiol. 2017;55(7):2064–73.

Nair SV, Kim HC, Fortunko J, et al. Aptima HIV-1 Quant Dx—automated diagnosis and quantification of HIV-1. J Clin Virol. 2016;77:46–54.

Racca S, Paolucci S, Lai A, et al. External quality assessment of HIV-1 DNA quantification assays. Sci Rep. 2022;12(1):3291.

Hardie D, Korsman S, Ameer S, et al. Reliability of plasma HIV viral load testing beyond 24 hours. PLoS One. 2019;14(7):e0219381.

Etienne L, Eymard-Duvernay S, Aghokeng A, et al. Real-time RT-PCR assay for genetically diverse HIV/SIV strains. J Clin Microbiol. 2013;51(3):787–98.

Tüzüner U, Gülcen BS, Özdemir M. Laboratory algorithm in HIV infection diagnosis. J HIV Clin Sci Res. 2016;3(1):007–10.

Wilson E, Tanzosh T, Maldarelli F. HIV diagnosis and testing: what healthcare professionals can do. Oral Dis. 2013;19(5):431–9.

Cornett JK, Kirn TJ. Laboratory diagnosis of HIV in adults: a review of current methods. Clin Infect Dis. 2013;57(5):712–8.

Alemnji G, Nkengasong JN, Parekh BS. HIV testing in developing countries: requirements. Indian J Med Res. 2011;134(6):779–86.

Parry JV, Mortimer PP, Perry KR, et al. Towards error-free HIV diagnosis: guidelines on lab practice. Commun Dis Public Health. 2003;6(4):334–50.

Koyio LN, Sanden WJMvd, Dimba E, et al. Oral health training increases HIV patient identification. PLoS One. 2014;9(3):e90927.